Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteriesThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.
| Publication | Article in Canadian Journal of Physiology and Pharmacology, published July 2010 |
|---|---|
| Authors | Faquan Liang, Christopher B. Glascock, Denise L. Schafer, Jennifer Sandoval, LouAnn Cable,...[ show more ] |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…